FDBusiness.com

Larch extract reduces cold incidence, says study

 Breaking News

Larch extract reduces cold incidence, says study

January 29
10:34 2013
Spread the love

A recently-published research study found that supplementation with larch arabinogalactan, provided in the study as Lonza’s proprietary immune support ingredient ResistAid, was associated with a statistically significant reduction (-23%) of the number of cold episodes in comparison with a placebo.

In addition, the percentage of study days that participants did not suffer from any cold symptoms was significantly higher in the group taking larch arabinogalactan (91.2%) compared to the placebo group (88.5%). The study, conducted by analyze & realize in Germany, has been published online in Current Medical Research and Opinion.

In the multi-centre, placebo-controlled, double-blind, randomised clinical trial, researchers measured the effect of supplementation with ResistAid on naturally acquired common cold episodes and its effect on cold symptoms was compared to a placebo.

Lonza notes that susceptibility to common colds is often related to a weak immune status or a lack of strong immune defence. Thus, the common cold was used as a model system to determine the effect of larch arabinogalactan on the human system against invading pathogens.

In the study, 199 healthy adults aged 18-70 with a self-reported rate of cold incidences of at least three in the prior six months were divided into two groups, taking either a daily larch arabinogalactan supplement of 4.5 grams or a placebo for 12 weeks. The participants documented each common cold episode in a diary and rated 10 predefined infection symptoms on a four-point rating scale during the infection period, resulting in an infection score. In addition to three prescheduled study visits, each common cold episode was confirmed by medical doctors.

About Author

colin

colin

Related Articles

Food & Drink Business Conference & Exhibition 2016

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements